×
About 2,775 results

ALLMedicine™ Prostatic Hyperplasia Center

Research & Reviews  681 results

Aquablation, Prostatic Urethral Lift, and Transurethral Water Vapor Therapy: A Comparis...
https://doi.org/10.1089/end.2021.0455
Journal of Endourology; Kaplan-Marans E, Martinez M et. al.

Jul 28th, 2021 - Aquablation, prostatic urethral lift (PUL), and transurethral water vapor therapy (TWVT) have demonstrated efficacy for the treatment of benign prostatic hyperplasia (BPH). Our objective was to describe device malfunctions and complications to hel...

Prolieve® Transurethral Thermodilatation for treatment of Symptomatic Benign Prostatic ...
https://doi.org/10.1089/end.2021.0240
Journal of Endourology; Olweny EO, Jow SL et. al.

Jul 28th, 2021 - Introduction & Objective Prolieve® transurethral thermodilatation (TUTD) is the only third-generation transurethral microwave thermotherapy (TUMT) device that incorporates balloon dilation/compression of the prostatic urethra with cooled TUMT, at ...

Insulin signaling, androgen receptor and PSMA immunohistochemical analysis by semi-auto...
https://doi.org/10.1016/j.trsl.2021.07.002
Translational Research : the Journal of Laboratory and Cl... Broggi G, Giudice AL et. al.

Jul 28th, 2021 - In the last years, many studies have highlighted the hypothesis that diabetes and hyperglycemia could be relevant for prostate cancer (PC) development and progression. We aimed to identify the prognostic value of tissue expression of androgen rece...

High regional variation in prostate surgery for benign prostatic hyperplasia in Switzer...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297757
PloS One; Wertli MM, Zumbrunn B et. al.

Jul 23rd, 2021 - Among various treatment options for benign prostatic hyperplasia (BPH), surgical therapy is the most invasive. As Switzerland has the highest transurethral prostatectomy rate among OECD countries, we assessed the regional variation in prostate sur...

see more →

Guidelines  3 results

Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hype...
https://doi.org/10.1097/JU.0000000000001298
The Journal of Urology; Parsons JK, Dahm P et. al.

Jul 24th, 2020 - The AUA Guideline panel provides evidence-based recommendations for the surgical management of male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). The Panel amended the Guideline in 2020 to reflect additional ...

Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hype...
https://doi.org/10.1097/JU.0000000000000319
The Journal of Urology; Foster HE, Dahm P et. al.

May 7th, 2019 - Male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is common in men and can have negative effects on quality of life (QoL). It is the hope that this Guideline becomes a reference for effective evidence-based s...

Korean clinical practice guideline for benign prostatic hyperplasia.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778754
Investigative and Clinical Urology; Yeo JK, Choi H et. al.

Mar 12th, 2016 - In 2014, the Korean Urological Association organized the Benign Prostatic Hyperplasia Guideline Developing Committee composed of experts in the field of benign prostatic hyperplasia (BPH) with the participation of the Korean Academy of Family Medi...

see more →

Drugs  336 results see all →

Clinicaltrials.gov  44 results

Benign Prostatic Hyperplasia (BPH) Mobile Application Pilot Study
https://clinicaltrials.gov/ct2/show/NCT03228485

May 1st, 2020 - Rationale: One of the next developments in healthcare is digitalization, including (mobile) applications that could support healthcare providers. A significant number of aging men suffer from lower urinary tract symptoms (LUTS), often caused by be...

Laser Prostatectomy Database and Registry
https://clinicaltrials.gov/ct2/show/NCT00159406

Mar 17th, 2020 - Benign prostatic hyperplasia (BPH) affects over 40% of men over the age of 60 (Kirby RS, 2000). For patients with significant obstructive symptoms which are not helped by medical therapy, surgical intervention is instituted. Transurethral resectio...

Changes of microRNA Expression in Obstructive and Neurogenic Bladder Dysfunction
https://clinicaltrials.gov/ct2/show/NCT02410876

Feb 5th, 2020 - Lower urinary tract dysfunction (LUTD) has multiple causes including bladder outlet obstruction (BOO) as a result of benign prostatic hyperplasia (BPH) and neurological diseases including spinal cord injury (SCI). Manifestations of LUTD include st...

Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)
https://clinicaltrials.gov/ct2/show/NCT01301599

Dec 2nd, 2019 - This study is designed to investigate the comparison between alpha blocker monotherapy and 5-alpha-reductase inhibitor monotherapy following combination therapy in benign prostatic hyperplasia.

Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)
https://clinicaltrials.gov/ct2/show/NCT03297398

Oct 18th, 2019 - Study SAR-202 is a phase 2 multicenter, placebo-controlled, double-blind trial to evaluate the effect of OPK-88004 doses (OPK-88004 15 mg, or OPK-88004 25 mg) on serum PSA compared to placebo in men with BPH. Approximately 115 men with BPH will be...

see more →

News  39 results

Complication Rates After Surgery for BPH: Real-World Data
https://www.medscape.com/viewarticle/954693

Jul 13th, 2021 - For patients with benign prostatic hyperplasia (BPH), there are several options when to comes to surgical treatment. A comparison of real-world outcomes reveals significant differences in postprocedural complication and re-treatment rates. The res...

Photoselective Vaporization Safely Alleviates Refractory LUTS in Prostate Cancer Patients
https://www.medscape.com/viewarticle/946349

Feb 25th, 2021 - NEW YORK (Reuters Health) - Photoselective vaporization of the prostate can provide relief from refractory lower-urinary-tract symptoms (LUTS) resulting from benign prostatic hyperplasia (BPH) in prostate cancer patients managed by active surveill...

Prostate Drugs Tied to Lower Risk for Parkinson's
https://www.medscape.com/viewarticle/945551

Feb 9th, 2021 - Certain drugs currently used to treat benign prostatic hyperplasia (BPH) may provide neuroprotection and delay or prevent the onset of Parkinson's disease, new research suggests. Treatment of BPH with terazosin (Hytrin), doxazosin (Cardura), or al...

Fast Five Quiz: Benign Prostatic Hyperplasia Key Aspects
https://reference.medscape.com/viewarticle/943651

Jan 12th, 2021 - Benign prostatic hyperplasia (BPH) is present in as many as 60% of men in their 60s and 90% of men older than 70 years. BPH describes nonmalignant prostate tissue growth and commonly causes lower urinary tract symptoms (LUTS). Not all men with BPH...

Urethral-Sparing Robot-Assisted Simple Prostatectomy Preserves Ejaculatory Function
https://www.medscape.com/viewarticle/941123

Nov 19th, 2020 - NEW YORK (Reuters Health) - Urethral-sparing robot-assisted simple prostatectomy (usRASP) preserves ejaculatory function while relieving lower-urinary-tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH), according to findings from...

see more →

Patient Education  7 results see all →